drugset / Trial / NCT07288697

Dose-Dependent Effects of Intraoperative Tranexamic Acid on Surgical Bleeding and Transfusion Requirements in Multilevel Thoracolumbar Spinal Surgery

NCT07288697

RandomizedParallel-groupSingle-blindPrevention

Summary

Multilevel spinal stabilization surgery is frequently associated with substantial blood loss and increased transfusion requirements. Tranexamic acid (TXA), an antifibrinolytic agent, reduces perioperative bleeding, but the optimal intravenous dosing regimen remains controversial. This study aimed to compare the efficacy and safety of two TXA dosing protocols in patients undergoing ≥3-level spinal stabilization surgery.

Timeline

Start
2023-11-01
Primary completion
2024-04-01
Completion
2024-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 mg/kg Intravenous
Comparator Tranexamic Acid Small molecule 2 mg/kg Intravenous